Skip to main content
SpringerLink
Log in

Sweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G

  • Chapter
  • First Online:
Fc Receptors

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 382))

Abstract

The importance of immunoglobulin G (IgG) molecules for providing long-term sterile immunity as well as their major contribution to tissue inflammation during autoimmune diseases is generally accepted. In a similar manner, studies over the last years have elucidated many details of the molecular and cellular pathways underlying this protective activity in vivo, emphasizing the role of cellular Fc receptors recognizing the constant antibody fragment. In contrast, the active anti-inflammatory activity of IgG, despite being known and actually identified in human autoimmune patients more than 30 years ago, is much less defined. Recent evidence from several independent model systems suggests that IgG glycosylation is critical for the immunomodulatory activity of IgG and that both monomeric IgG as well as IgG immune complexes can diminish Fc receptor and complement dependent inflammatory processes. Moreover, there is increasing evidence that IgG molecules also modulate B and T cell responses, which may suggest that IgG is centrally involved in the establishment and maintenance of immune homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anthony RM, Ravetch JV (2010) A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol 30(Suppl 1):S9–S14

    PubMed  CAS  Google Scholar 

  • Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV (2008a) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320:373–376

    PubMed  CAS  PubMed Central  Google Scholar 

  • Anthony RM, Wermeling F, Karlsson MC, Ravetch JV (2008b) Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA 105:19571–19578

    PubMed  CAS  PubMed Central  Google Scholar 

  • Anthony RM, Kobayashi T, Wermeling F, Ravetch JV (2011) Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 475:110–113

    PubMed  CAS  PubMed Central  Google Scholar 

  • Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21–50

    PubMed  CAS  Google Scholar 

  • Baerenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp G, Dudziak D, Nimmerjahn F (2011) Fcgamma receptor IIB (FcgammaRIIB) maintains humoral tolerance in the human immune system in vivo. Proc Natl Acad Sci USA 108:18772–18777

    Google Scholar 

  • Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV (2003) Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101:758–765

    PubMed  CAS  Google Scholar 

  • Bayry J, Fournier EM, Maddur MS, Vani J, Wootla B, Siberil S, Dimitrov JD, Lacroix-Desmazes S, Berdah M, Crabol Y, Oksenhendler E, Levy Y, Mouthon L, Sautes-Fridman C, Hermine O, Kaveri SV (2011a) Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. J Autoimmun 36:9–15

    PubMed  CAS  Google Scholar 

  • Bayry J, Negi VS, Kaveri SV (2011b) Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol 7:349–359

    PubMed  CAS  Google Scholar 

  • Beers SA, Cragg MS, Glennie MJ (2009) Complement: help or hindrance? Blood 114:5567–5568 (author reply 5568)

    Google Scholar 

  • Bohm S, Schwab I, Lux A, Nimmerjahn F (2012) The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol 34:443–453

    PubMed  Google Scholar 

  • Bolland S, Ravetch JV (1999) Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol 72:149–177

    PubMed  CAS  Google Scholar 

  • Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13:277–285

    PubMed  CAS  Google Scholar 

  • Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV (2002) Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 195:1167–1174

    PubMed  CAS  PubMed Central  Google Scholar 

  • Boross P, Arandhara VL, Martin-Ramirez J, Santiago-Raber ML, Carlucci F, Flierman R, van der Kaa J, Breukel C, Claassens JW, Camps M, Lubberts E, Salvatori D, Rastaldi MP, Ossendorp F, Daha MR, Cook HT, Izui S, Botto M, Verbeek JS (2011) The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility. J Immunol 187:1304–1313

    PubMed  CAS  Google Scholar 

  • Brownlie RJ, Lawlor KE, Niederer HA, Cutler AJ, Xiang Z, Clatworthy MR, Floto RA, Greaves DR, Lyons PA, Smith KG (2008) Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med 205:883–895

    PubMed  CAS  PubMed Central  Google Scholar 

  • Bruhns P, Samuelsson A, Pollard JW, Ravetch JV (2003) Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18:573–581

    PubMed  CAS  Google Scholar 

  • Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545–568

    PubMed  CAS  Google Scholar 

  • Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99:754–758

    PubMed  CAS  Google Scholar 

  • Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, Mao CZ, Chu JY, Tokunaga K (2004) Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63:21–27

    PubMed  CAS  Google Scholar 

  • Clynes R, Ravetch JV (1995) Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3:21–26

    PubMed  CAS  Google Scholar 

  • Crispin M, Yu X, Bowden TA (2013) Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy. Proc Natl Acad Sci USA 110:E3544–E3546

    PubMed  CAS  PubMed Central  Google Scholar 

  • Crow AR, Song S, Semple JW, Freedman J, Lazarus AH (2001) IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity. Br J Haematol 115:679–686

    PubMed  CAS  Google Scholar 

  • Crow AR, Song S, Semple JW, Freedman J, Lazarus AH (2007) A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 109:155–158

    PubMed  CAS  Google Scholar 

  • Daeron M, Lesourne R (2006) Negative signaling in Fc receptor complexes. Adv Immunol 89:39–86

    PubMed  CAS  Google Scholar 

  • Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA (2014) Emerging principles for the therapeutic exploitation of glycosylation. Science 343:1235681

    PubMed  Google Scholar 

  • de Groot AS, Moise L, McMurry JA, Wambre E, van Overtvelt L, Moingeon P, Scott DW, Martin W (2008) Activation of natural regulatory T cells by IgG Fc-derived peptide “Tregitopes”. Blood 112:3303–3311

    PubMed  PubMed Central  Google Scholar 

  • Debre M, Bonnet MC, Fridman WH, Carosella E, Philippe N, Reinert P, Vilmer E, Kaplan C, Teillaud JL, Griscelli C (1993) Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 342:945–949

    PubMed  CAS  Google Scholar 

  • Dube R, Rook GA, Steele J, Brealey R, Dwek R, Rademacher T, Lennard-Jones J (1990) Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 31:431–434

    PubMed  CAS  PubMed Central  Google Scholar 

  • Durandy A, Kaveri SV, Kuijpers TW, Basta M, Miescher S, Ravetch JV, Rieben R (2009) Intravenous immunoglobulins–understanding properties and mechanisms. Clin Exp Immunol 158(Suppl 1):2–13

    PubMed  CAS  PubMed Central  Google Scholar 

  • Stadlmann J, Weber A, Pabst M, Anderle H, Kunert R, Ehrlich, HJ, Peter Schwarz H, Altmann F (2009) A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics 9:4143–4153

    Google Scholar 

  • Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, Delignat S, Elluru S, Bayry J, Lacroix-Desmazes S, Cohen JL, Salomon BL, Kazatchkine MD, Kaveri SV, Misra N (2008) Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 111:715–722

    PubMed  CAS  Google Scholar 

  • Espeli M, Clatworthy MR, Bokers S, Lawlor KE, Cutler AJ, Kontgen F, Lyons PA, Smith KG (2012) Analysis of a wild mouse promoter variant reveals a novel role for FcgammaRIIb in the control of the germinal center and autoimmunity. J Exp Med 209(12):2307–2319

    Google Scholar 

  • Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, Umana P, Benz J (2011) Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci USA 108:12669–12674

    PubMed  CAS  PubMed Central  Google Scholar 

  • Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, Macary PA, Rankin A, Lehner PJ, Ouwehand WH, Allen JM, Watkins NA, Smith KG (2005) Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 11:1056–1058

    PubMed  CAS  Google Scholar 

  • Fukuyama H, Nimmerjahn F, Ravetch JV (2005) The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 6:99–106

    PubMed  CAS  Google Scholar 

  • Garred P, Madsen HO, Marquart H, Hansen TM, Sorensen SF, Petersen J, Volck B, Svejgaard A, Graudal NA, Rudd PM, Dwek RA, Sim RB, Andersen V (2000) Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 27:26–34

    PubMed  CAS  Google Scholar 

  • Ghirlando R, Lund J, Goodall M, Jefferis R (1999) Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry. Immunol Lett 68:47–52

    PubMed  CAS  Google Scholar 

  • Guhr T, Bloem J, Derksen NI, Wuhrer M, Koenderman AH, Aalberse RC, Rispens T (2011) Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS ONE 6:e21246

    PubMed  CAS  PubMed Central  Google Scholar 

  • Hadley AG, Zupanska B, Kumpel BM, Pilkington C, Griffiths HL, Leader KA, Jones J, Booker DJ, Stamps R, Sokol RJ (1995) The glycosylation of red cell autoantibodies affects their functional activity in vitro. Br J Haematol 91:587–594

    PubMed  CAS  Google Scholar 

  • Hess C, Winkler A, Lorenz AK, Holecska V, Blanchard V, Eiglmeier S, Schoen AL, Bitterling J, Stoehr AD, Petzold D, Schommartz T, Mertes MM, Schoen CT, Tiburzy B, Herrmann A, Kohl J, Manz RA, Madaio MP, Berger M, Wardemann H, Ehlers M (2013) T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J Clin Invest 123:3788–3796

    PubMed  CAS  PubMed Central  Google Scholar 

  • Heyman B (2000) Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 18:709–737

    PubMed  CAS  Google Scholar 

  • Hogarth PM, Pietersz GA (2012) Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov 11:311–331

    PubMed  CAS  Google Scholar 

  • Holland M, Takada K, Okumoto T, Takahashi N, Kato K, Adu D, Ben-Smith A, Harper L, Savage CO, Jefferis R (2002) Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol 129:183–190

    PubMed  CAS  PubMed Central  Google Scholar 

  • Huang HS, Sun DS, Lien TS, Chang HH (2010) Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice. Blood 116:5002–5009

    PubMed  CAS  Google Scholar 

  • Imbach P (2012) Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review. Swiss Med Wkly 142:w13593

    Google Scholar 

  • Imbach P, Barandun S, D’Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schoni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228–1231

    PubMed  CAS  Google Scholar 

  • Jellusova J, Nitschke L (2011) Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol 2:96

    PubMed  PubMed Central  Google Scholar 

  • Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV (2006a) Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203:789–797 (Epub 2006 Mar 6)

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kaneko Y, Nimmerjahn F, Ravetch JV (2006b) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670–673

    PubMed  CAS  Google Scholar 

  • Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ, Berger M, Petzold D, Blanchard V, Winkler A, Hess C, Reid DM, Majoul IV, Strait RT, Harris NL, Kohl G, Wex E, Ludwig R, Zillikens D, Nimmerjahn F, Finkelman FD, Brown GD, Ehlers M, Kohl J (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med 18:1401–1406

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kasermann F, Boerema DJ, Ruegsegger M, Hofmann A, Wymann S, Zuercher AW, Miescher S (2012) Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PLoS ONE 7:e37243

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kasperkiewicz M, Nimmerjahn F, Wende S, Hirose M, Iwata H, Jonkman MF, Samavedam U, Gupta Y, Moller S, Rentz E, Hellberg L, Kalies K, Yu X, Schmidt E, Hasler R, Laskay T, Westermann J, Kohl J, Zillikens D, Ludwig RJ (2012a) Genetic identification and functional validation of FcgammaRIV as key molecule in autoantibody-induced tissue injury. J Pathol 228:8–19

    PubMed  CAS  Google Scholar 

  • Kasperkiewicz M, Schmidt E, Zillikens D (2012b) Current therapy of the pemphigus group. Clin Dermatol 30:84–94

    PubMed  Google Scholar 

  • Kono H, Kyogoku C, Suzuki T, Tsuchiya N, Honda H, Yamamoto K, Tokunaga K, Honda Z (2005) FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 14:2881–2892 (Epub 2005 Aug 22)

    PubMed  CAS  Google Scholar 

  • Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P (2003) Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 325:979–989

    PubMed  CAS  Google Scholar 

  • Kumpel BM, Wang Y, Griffiths HL, Hadley AG, Rook GA (1995) The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. Hum Antibodies Hybridomas 6:82–88

    PubMed  CAS  Google Scholar 

  • Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JG, Kallenberg CG, Tokunaga K (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46:1242–1254

    PubMed  CAS  Google Scholar 

  • Lehmann B, Schwab I, Bohm S, Lux A, Biburger M, Nimmerjahn F (2012) FcgammaRIIB: a modulator of cell activation and humoral tolerance. Expert Rev Clin Immunol 8:243–254

    PubMed  CAS  Google Scholar 

  • Leontyev D, Katsman Y, Ma XZ, Miescher S, Kasermann F, Branch DR (2012) Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin. Transfusion 52:1799–1805

    PubMed  CAS  Google Scholar 

  • Mackay M, Stanevsky A, Wang T, Aranow C, Li M, Koenig S, Ravetch JV, Diamond B (2006) Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 203:2157–2164

    PubMed  CAS  PubMed Central  Google Scholar 

  • Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237–243

    PubMed  CAS  Google Scholar 

  • McGaha TL, Sorrentino B, Ravetch JV (2005) Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307:590–593

    PubMed  CAS  Google Scholar 

  • McGaha TL, Karlsson MC, Ravetch JV (2008) FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol 180:5670–5679

    PubMed  CAS  Google Scholar 

  • Mehta AS, Long RE, Comunale MA, Wang M, Rodemich L, Krakover J, Philip R, Marrero JA, Dwek RA, Block TM (2008) Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol 82:1259–1270

    PubMed  CAS  PubMed Central  Google Scholar 

  • Mihai S, Nimmerjahn F (2012) The role of Fc receptors and complement in autoimmunity. Autoimmun Rev 12(6):657–660

    Google Scholar 

  • Musolino A, Naldi N, Bortesi B, Pezzuolo D, Capelletti M, Missale G, Laccabue D, Zerbini A, Camisa R, Bisagni G, Neri TM, Ardizzoni A (2008) Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J Clin Oncol 26:1789–1796

    PubMed  CAS  Google Scholar 

  • Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV (2007) Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 27:233–245

    PubMed  CAS  Google Scholar 

  • Nikolova KA, Tchorbanov AI, Djoumerska-Alexieva IK, Nikolova M, Vassilev TL (2009) Intravenous immunoglobulin up-regulates the expression of the inhibitory FcgammaIIB receptor on B cells. Immunol Cell Biol 87:529–533

    PubMed  CAS  Google Scholar 

  • Nimmerjahn F (ed) (2013) Molecular and cellular mechanisms of antibody activity. Springer, New York

    Google Scholar 

  • Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310:1510–1512

    PubMed  CAS  Google Scholar 

  • Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24:19–28

    PubMed  CAS  Google Scholar 

  • Nimmerjahn F, Ravetch JV (2007) The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 204:11–15

    PubMed  CAS  PubMed Central  Google Scholar 

  • Nimmerjahn F, Ravetch JV (2012) Translating basic mechanisms of IgG effector activity into next generation cancer therapies. Cancer Immun 12:13

    PubMed  PubMed Central  Google Scholar 

  • Nimmerjahn F, Anthony RM, Ravetch JV (2007) Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 104:8433–8437

    PubMed  CAS  PubMed Central  Google Scholar 

  • Oefner CM, Winkler A, Hess C, Lorenz AK, Holecska V, Huxdorf M, Schommartz T, Petzold D, Bitterling J, Schoen AL, Stoehr AD, Van Vu D, Darcan-Nikolaisen Y, Blanchard V, Schmudde I, Laumonnier Y, Strover HA, Hegazy AN, Eiglmeier S, Schoen CT, Mertes MM, Loddenkemper C, Lohning M, Konig P, Petersen A, Luger EO, Collin M, Kohl J, Hutloff A, Hamelmann E, Berger M, Wardemann H, Ehlers M (2012) Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol 129:1647–1655 e13

    Google Scholar 

  • Otani M, Kuroki A, Kikuchi S, Kihara M, Nakata J, Ito K, Furukawa J, Shinohara Y, Izui S (2012) Sialylation determines the nephritogenicity of IgG3 cryoglobulins. J Am Soc Nephrol 23:1869–1878

    PubMed  CAS  PubMed Central  Google Scholar 

  • Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, Rademacher TW (1988) Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1:966–969

    PubMed  CAS  Google Scholar 

  • Park-Min KH, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB (2007) FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity 26:67–78

    PubMed  CAS  Google Scholar 

  • Pearse RN, Kawabe T, Bolland S, Guinamard R, Kurosaki T, Ravetch JV (1999) SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. Immunity 10:753–760

    PubMed  CAS  Google Scholar 

  • Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10:227–230

    PubMed  CAS  Google Scholar 

  • Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T, Hiepe F (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6:741–750

    PubMed  CAS  Google Scholar 

  • Rademacher TW, Williams P, Dwek RA (1994) Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci USA 91:6123–6127

    PubMed  CAS  PubMed Central  Google Scholar 

  • Ravetch JV, Nimmerjahn F (2008) Fc receptors. In: Paul WE (ed) Fundamental immunology, 5th edn. Lippincott-Raven, Philadelphia

    Google Scholar 

  • Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA (2001) Glycosylation and the immune system. Science 291:2370–2376

    PubMed  CAS  Google Scholar 

  • Rudge EU, Cutler AJ, Pritchard NR, Smith KG (2002) Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J Exp Med 195:1079–1085

    PubMed  CAS  PubMed Central  Google Scholar 

  • Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484–486

    PubMed  CAS  Google Scholar 

  • Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS (2007) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524–1534

    PubMed  CAS  Google Scholar 

  • Scherer HU, van der Woude D, Ioan-Facsinay A, el Bannoudi H, Trouw LA, Wang J, Haupl T, Burmester GR, Deelder AM, Huizinga TW, Wuhrer M, Toes RE (2010) Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum 62:1620–1629

    PubMed  CAS  Google Scholar 

  • Schmidt RE, Gessner JE (2005) Fc receptors and their interaction with complement in autoimmunity. Immunol Lett 100:56–67

    PubMed  CAS  Google Scholar 

  • Schwab I, Nimmerjahn F (2013) Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13:176–189

    PubMed  CAS  Google Scholar 

  • Schwab I, Biburger M, Kronke G, Schett G, Nimmerjahn F (2012a) IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1. Eur J Immunol 42:826–830

    PubMed  CAS  Google Scholar 

  • Schwab I, Seeling M, Biburger M, Aschermann S, Nitschke L, Nimmerjahn F (2012b) B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo. Eur J Immunol 42(12):3302–3309

    Google Scholar 

  • Schwab I, Mihai S, Seeling M, Kasperkiewicz M, Ludwig R, Nimmerjahn F (2014) Broad requirement for terminal sialic acid residues and FcgRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo. Eur J Immunol 44(5):1444–1453

    Google Scholar 

  • Seite JF, Shoenfeld Y, Youinou P, Hillion S (2008) What is the contents of the magic draft IVIg? Autoimmun Rev 7:435–439

    PubMed  Google Scholar 

  • Seite JF, Cornec D, Renaudineau Y, Youinou P, Mageed RA, Hillion S (2010) IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 116:1698–1704

    PubMed  CAS  Google Scholar 

  • Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA, Presta LG (2001) High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 276:6591–6604

    PubMed  CAS  Google Scholar 

  • Shields RL, Lai J, Keck R, O’Connell LY, Hong K, Meng YG, Weikert SH, Presta LG (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277:26733–26740 (Epub 2002 May 1)

    PubMed  CAS  Google Scholar 

  • Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466–3473 (Epub 2002 Nov 8)

    PubMed  CAS  Google Scholar 

  • Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH (2006) Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med 12:688–692 (Epub 2006 May 21)

    PubMed  CAS  Google Scholar 

  • Smith KG, Clatworthy MR (2010) FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 10:328–343

    PubMed  CAS  PubMed Central  Google Scholar 

  • Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV (2013) General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci USA 110:9868–9872

    PubMed  CAS  PubMed Central  Google Scholar 

  • Su K, Li X, Edberg JC, Wu J, Ferguson P, Kimberly RP (2004a) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol 172:7192–7199

    PubMed  CAS  Google Scholar 

  • Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS, Langefeld CD, Kimberly RP (2004b) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 172:7186–7191

    PubMed  CAS  Google Scholar 

  • Su K, Yang H, Li X, Gibson AW, Cafardi JM, Zhou T, Edberg JC, Kimberly RP (2007) Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol 178:3272–3280

    PubMed  CAS  PubMed Central  Google Scholar 

  • Syed SN, Konrad S, Wiege K, Nieswandt B, Nimmerjahn F, Schmidt RE, Gessner JE (2009) Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur J Immunol 39:3343–3356

    PubMed  CAS  Google Scholar 

  • Sylvestre DL, Ravetch JV (1994) Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265:1095–1098

    PubMed  CAS  Google Scholar 

  • Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV (1996) Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 184:2385–2392

    PubMed  CAS  PubMed Central  Google Scholar 

  • Tackenberg B, Jelcic I, Baerenwaldt A, Oertel WH, Sommer N, Nimmerjahn F, Lunemann JD (2009) Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci USA 106:4788–4792

    PubMed  CAS  PubMed Central  Google Scholar 

  • Takai T (2002) Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2:580–592

    PubMed  CAS  Google Scholar 

  • Tomana M, Schrohenloher RE, Koopman WJ, Alarcon GS, Paul WA (1988) Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 31:333–338

    PubMed  CAS  Google Scholar 

  • Tremblay T, Pare I, Bazin R (2012) Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia. Transfusion 53(2):261–269

    Google Scholar 

  • Tzeng SJ, Bolland S, Inabe K, Kurosaki T, Pierce SK (2005) The B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl-family kinase dependent pathway. J Biol Chem 22:22

    Google Scholar 

  • van de Geijn FE, Hazes JM, Geleijns K, Emonts M, Jacobs BC, Dufour-van den Goorbergh BC, Dolhain RJ (2008) Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis: confirmation in two large cohorts. Rheumatology (Oxford) 47:1168–1171

    Google Scholar 

  • van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, Deelder AM, Hazes JM, Dolhain RJ (2009) Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 11:R193

    PubMed  PubMed Central  Google Scholar 

  • van de Geijn FE, de Man YA, Wuhrer M, Willemsen SP, Deelder AM, Hazes JM, Dolhain RJ (2011) Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis. Arthritis Res Ther 13:R10

    PubMed  PubMed Central  Google Scholar 

  • Walker MR, Lund J, Thompson KM, Jefferis R (1989) Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Biochem J 259:347–353

    PubMed  CAS  PubMed Central  Google Scholar 

  • Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, Deelder AM, Huizinga TW, Toes RE, Wuhrer M (2011) Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Proteomics 10(M110):004655

    PubMed  Google Scholar 

  • Weng WK, Levy R (2003) Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 21:3940–3947 (Epub 2003 Sep 15)

    PubMed  CAS  Google Scholar 

  • Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R (2004) Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. J Clin Oncol 22:4717–4724 (Epub 2004 Oct 13)

    PubMed  CAS  Google Scholar 

  • Willcocks LC, Carr EJ, Niederer HA, Rayner TF, Williams TN, Yang W, Scott JA, Urban BC, Peshu N, Vyse TJ, Lau YL, Lyons PA, Smith KG (2010) A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci USA 107:7881–7885

    PubMed  CAS  PubMed Central  Google Scholar 

  • Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, Dwek RA (1997) Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36:1370–1380

    PubMed  CAS  Google Scholar 

  • Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, Walker EU, Manz RA, Tarlinton DM, Smith KG (2007) FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8:419–429

    PubMed  CAS  Google Scholar 

  • Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, Nussenzweig MC, Steinman RM (2008) CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3 + regulatory T cells. J Immunol 181:6923–6933

    PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

We apologize to all our colleagues whose important work could not be cited directly due to limited amount of space. These references can be found in the different review articles cited in the manuscript. This work was supported by grants from the German Research Foundation the Bavarian Genome Research Network, and by the CAVD network within the Bill and Melinda Gates Foundation.

Author information

Authors and Affiliations

  1. Department of Biology, Institute of Genetics, University of Erlangen-Nürnberg, Erwin-Rommelstr. 3, 91058, Erlangen, Germany

    Sybille Böhm, Daniela Kao & Falk Nimmerjahn

Authors
  1. Sybille Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Kao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Falk Nimmerjahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Falk Nimmerjahn .

Editor information

Editors and Affiliations

  1. Institut Pasteur, Paris, France

    Marc Daeron

  2. Department of Biology, Institute of Genetics, University of Erlangen-Nürnberg, Erlangen, Germany

    Falk Nimmerjahn

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Böhm, S., Kao, D., Nimmerjahn, F. (2014). Sweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G. In: Daeron, M., Nimmerjahn, F. (eds) Fc Receptors. Current Topics in Microbiology and Immunology, vol 382. Springer, Cham. https://doi.org/10.1007/978-3-319-07911-0_18

Download citation

Publish with us

Policies and ethics

Search

Navigation